About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Analysis of Plasma Tumor DNA in Lung Cancer Patients

NCT01930474·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Hyun Chang, Dr.
CONTACT
82-31-787-7039 [email protected]

Lead

Seoul National University Hospital

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Have a histologically or cytologically confirmed diagnosis of non-small cell lung cancer
Have molecular evidence of genetic alterations in tumor sample (eg. EGFR mutations, ALK fusions)
Patients must have given written informed consent

You may not be if

Patients who refuse the blood samplings

The record

StatusUnknown

PhaseNo phase

Taking part200

StartedJul 2013

UpdatedDec 5, 2013

Conditions

Non Small Cell Lung Cancer Patients

Where1

Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea

Clareo Health | Analysis of Plasma Tumor DNA in Lung Cancer Patients